Search

everythinglearnresearchcommunity

for

Search:↓

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Cerebronal® may help improve certain brain health markers.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Tailored treatments for aging brows and foreheads improve results.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Women with Frontal Fibrosing Alopecia have more wrinkles near their ears than similar aged women without the condition.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

The incision along the superior temporal line is safe and looks good for bald male patients.

Bumps on the face may be an early sign of a type of hair loss called frontal fibrosing alopecia.

Frontal fibrosing alopecia can affect African men and may be underdiagnosed.

Excessive sun protection might contribute to frontal fibrosing alopecia.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Finasteride effectively treats frontal hair loss with few side effects.